FIELD: medicine, laboratory diagnostics.
SUBSTANCE: the present innovation deals with predicting the risk of the relapse of endometrioid ovarian cyst due to immunohistochemical detecting the values of the expression of matrix metalloproteinase-7 and the inhibitor of matrix metalloproteinase-TIMP-4 and according to these values one should predict the relapse of endometrioid ovarian cyst long before the appearance of clinical signs.
EFFECT: higher accuracy of prediction.
3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RECURRENT ENDOMETRIOID OVARIAN CYSTS | 2018 |
|
RU2694882C1 |
| METHOD OF DETERMINING RISK OF RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT | 2023 |
|
RU2811890C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF ENDOMETRIAL CYSTS AFTER SURGICAL TREATMENT BY MEANS OF IMMUNOHISTOCHEMICAL MARKERS | 2017 |
|
RU2681219C1 |
| METHOD FOR DETERMINATION OF ENDOMETRIOID OVARIAN FORMATIONS TYPE | 2016 |
|
RU2625751C1 |
| METHOD FOR PREDICTING RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT | 2021 |
|
RU2757236C1 |
| METHOD TO PREDICT RECURRENCE OF INFILTRATIVE PELVIC ENDOMETRIOSIS BASED ON THE RESULT OF EXPRESSION OF IMMUNOHISTOCHEMICAL MUSASHIL MARKER IN ENDOMETRIOIDAL TISSUE | 2016 |
|
RU2636506C1 |
| METHOD FOR PREDICTICTION OF EARLY RECURRENCE OF SUPERFICIAL BLADDER CANCER | 2016 |
|
RU2635534C1 |
| METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 |
|
RU2730952C1 |
| METHOD FOR ASSESSING ENDOMETRIAL RECEPTIVENESS IN ENDOMETRIOSIS-ASSOCIATED INFERTILITY | 2020 |
|
RU2724381C1 |
| METHOD FOR PREDICTING PLACENTA GROWTH DURING PREGNANCY | 2018 |
|
RU2679641C1 |
